Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening

Lignende værker

• Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values
  af: Catalona, William J., et al.
  Udgivet: (2010)
• What Is the True Mortality Benefit of Prostate-Specific Antigen Screening?
  af: Loeb, Stacy, et al.
  Udgivet: (2010)
• Prostate-specific antigen screening can be beneficial to younger and at-risk men
  af: Roobol, Monique J., et al.
  Udgivet: (2013)
• Prostate-Specific Antigen (PSA)–Based Population Screening for Prostate Cancer: An Evidence-Based Analysis
  af: Pron, G
  Udgivet: (2015)
• Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer
  af: Loeb, Stacy, et al.
  Udgivet: (2012)